ArticleAnnals of clinical and translational neurology2026

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti-AChR Antibody-Positive Myasthenia Gravis: FGF-19 as a Novel Biomarker.

Tiancheng Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.